Broadfin Capital’s Dynavax Technologies DVAX Stock Holding History

Broadfin Capital’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,347,810	Closed	-$14.1M	–	65
2016 Q3	$14.1M	Buy	1,347,810 +800,000	+146%	+$11.5M	1.27%	22
2016 Q2	$7.99M	Hold	547,810	–	–	0.78%	34
2016 Q1	$10.5M	Sell	547,810 -81,900	-13%	-$1.66M	1.02%	28
2015 Q4	$15.2M	Sell	629,710 -160,000	-20%	-$4.01M	0.94%	27
2015 Q3	$19.4M	Buy	789,710 +23,700	+3%	+$671K	1.08%	17
2015 Q2	$17.9M	Hold	766,010	–	–	0.96%	29
2015 Q1	$17.2M	Hold	766,010	–	–	1.34%	19
2014 Q4	$12.9M	Hold	766,010	–	–	1.12%	25
2014 Q3	$11M	Hold	766,010	–	–	1.15%	26
2014 Q2	$12.3M	Hold	766,010	–	–	1.2%	25
2014 Q1	$13.8M	Buy	766,010 +41,010	+6%	+$761K	1.34%	27
2013 Q4	$14.2M	Buy	+725,000	New	+$10.6M	1.87%	20

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Broadfin Capital's DVAX Position: Q4 2016 in Review

Broadfin Capital sold out of Dynavax Technologies (DVAX) in Q4 2016, closing a stake of 1,347,810 shares — an estimated $14.1M sold.

Broadfin Capital first reported a position in DVAX in Q4 2013 and held it in 12 quarters. The position peaked at $19.4M in Q3 2015. 111 funds tracked by Wall St. Rank hold DVAX as of Q4 2016.

Broadfin Capital reported no remaining Dynavax Technologies position as of Q4 2016 after selling out during the quarter.
Broadfin Capital sold 1,347,810 Dynavax Technologies shares in Q4 2016, an estimated $14.1M.
Broadfin Capital first reported a position in Dynavax Technologies in Q4 2013 and held it in 12 quarters.
Broadfin Capital's Dynavax Technologies position peaked at $19.4M in Q3 2015.
111 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2016.

Based on Broadfin Capital's 13F filing for Q4 2016, filed 14 Feb 2017.